Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)

MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated:  12/31/1969
SUNY-University of Buffalo
mi
from
Buffalo, NY
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated: 12/31/1969
SUNY-University of Buffalo
mi
from
Buffalo, NY
Click here to add this to my saved trials
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated:  12/31/1969
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated: 12/31/1969
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated:  12/31/1969
Temple University
mi
from
Philadelphia, PA
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated: 12/31/1969
Temple University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated:  12/31/1969
Texas Tech University Health Science Center
mi
from
Amarillo, TX
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated: 12/31/1969
Texas Tech University Health Science Center
mi
from
Amarillo, TX
Click here to add this to my saved trials
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated:  12/31/1969
Memorial Hermann Hospital System
mi
from
Houston, TX
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated: 12/31/1969
Memorial Hermann Hospital System
mi
from
Houston, TX
Click here to add this to my saved trials
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated:  12/31/1969
University of Utah
mi
from
Salt Lake City, UT
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin
mi
from
Madison, WI
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated:  12/31/1969
Milwaukee Health Services, INC
mi
from
Milwaukee, WI
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated: 12/31/1969
Milwaukee Health Services, INC
mi
from
Milwaukee, WI
Click here to add this to my saved trials
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated:  12/31/1969
Wheaton Franciscan Medical Group
mi
from
Milwaukee, WI
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
Status: Enrolling
Updated: 12/31/1969
Wheaton Franciscan Medical Group
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Regadenoson for Acute Vasoreactivity Testing in Pulmonary Hypertension
Regadenoson for Acute Vasoreactivity Testing in Pulmonary Hypertension
Status: Enrolling
Updated:  12/31/1969
National Jewish Health
mi
from
Denver, CO
Regadenoson for Acute Vasoreactivity Testing in Pulmonary Hypertension
Regadenoson for Acute Vasoreactivity Testing in Pulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
National Jewish Health
mi
from
Denver, CO
Click here to add this to my saved trials
Biomarker Guided Therapies in Stage A/B Heart Failure
Biomarker Guided Therapies in Stage A/B Heart Failure
Status: Enrolling
Updated:  12/31/1969
Michael E. DeBakey VA Medical Center, Houston, TX
mi
from
Houston, TX
Biomarker Guided Therapies in Stage A/B Heart Failure
Biomarker Guided Therapies in Stage A/B Heart Failure
Status: Enrolling
Updated: 12/31/1969
Michael E. DeBakey VA Medical Center, Houston, TX
mi
from
Houston, TX
Click here to add this to my saved trials
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated:  12/31/1969
Advanced Research Center, Inc.
mi
from
Anaheim, CA
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated: 12/31/1969
Advanced Research Center, Inc.
mi
from
Anaheim, CA
Click here to add this to my saved trials
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated:  12/31/1969
JDH Medical Group
mi
from
Miami, FL
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated: 12/31/1969
JDH Medical Group
mi
from
Miami, FL
Click here to add this to my saved trials
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated:  12/31/1969
University of Miami and Jackson Memorial Hospital
mi
from
Miami, FL
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated: 12/31/1969
University of Miami and Jackson Memorial Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated:  12/31/1969
University of Louisville
mi
from
Louisville, KY
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated: 12/31/1969
University of Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated:  12/31/1969
David M. Headley, MD PA
mi
from
Port Gibson, MS
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated: 12/31/1969
David M. Headley, MD PA
mi
from
Port Gibson, MS
Click here to add this to my saved trials
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated:  12/31/1969
Mount Sinai PRIME
mi
from
Lake Success, NY
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated: 12/31/1969
Mount Sinai PRIME
mi
from
Lake Success, NY
Click here to add this to my saved trials
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated:  12/31/1969
SouthEast Texas Clinical Research Center
mi
from
Beaumont, TX
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated: 12/31/1969
SouthEast Texas Clinical Research Center
mi
from
Beaumont, TX
Click here to add this to my saved trials
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated:  12/31/1969
Texas Children's Heart Center
mi
from
Houston, TX
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated: 12/31/1969
Texas Children's Heart Center
mi
from
Houston, TX
Click here to add this to my saved trials
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated:  12/31/1969
Ericksen Research And Development
mi
from
Clinton, UT
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated: 12/31/1969
Ericksen Research And Development
mi
from
Clinton, UT
Click here to add this to my saved trials
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated:  12/31/1969
Hospital Italiano
mi
from
Ciudad Autonoma,
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated: 12/31/1969
Hospital Italiano
mi
from
Ciudad Autonoma,
Click here to add this to my saved trials
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated:  12/31/1969
Medical Research Center of Miami II, Inc.
mi
from
Miami, FL
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated: 12/31/1969
Medical Research Center of Miami II, Inc.
mi
from
Miami, FL
Click here to add this to my saved trials
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated:  12/31/1969
Georgia Clinical Research, LLC
mi
from
Snellville, GA
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated: 12/31/1969
Georgia Clinical Research, LLC
mi
from
Snellville, GA
Click here to add this to my saved trials
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated:  12/31/1969
Zoe Center for Pediatrics
mi
from
Thomaston, GA
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated: 12/31/1969
Zoe Center for Pediatrics
mi
from
Thomaston, GA
Click here to add this to my saved trials
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated:  12/31/1969
Direct Helpers Research Center
mi
from
Hialeah, FL
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated: 12/31/1969
Direct Helpers Research Center
mi
from
Hialeah, FL
Click here to add this to my saved trials
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated:  12/31/1969
Pioneer Clinical Research
mi
from
North Miami, FL
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated: 12/31/1969
Pioneer Clinical Research
mi
from
North Miami, FL
Click here to add this to my saved trials
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated:  12/31/1969
Memphis and Shelby County Pediatric Group
mi
from
Memphis, TN
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated: 12/31/1969
Memphis and Shelby County Pediatric Group
mi
from
Memphis, TN
Click here to add this to my saved trials
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated:  12/31/1969
Mid Columbia Research
mi
from
Richland, WA
An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension
A Randomized, Double-Blind, Efficacy and Safety Study of AR 14 (AZILSARTAN MEDOXOMIL) Treatment and Withdrawal, Followed by an Open-Label Extension, in Children 6 to Less Than 18 Years of Age With Hypertension
Status: Enrolling
Updated: 12/31/1969
Mid Columbia Research
mi
from
Richland, WA
Click here to add this to my saved trials
Tissue Sodium in Pre-hypertensive Patients
Tissue Sodium in Pre-hypertensive Patients
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Tissue Sodium in Pre-hypertensive Patients
Tissue Sodium in Pre-hypertensive Patients
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  12/31/1969
Arizona Glaucoma Specialists
mi
from
Phoenix, AZ
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/31/1969
Arizona Glaucoma Specialists
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  12/31/1969
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/31/1969
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  12/31/1969
Lugene Eye Institute
mi
from
Glendale, CA
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/31/1969
Lugene Eye Institute
mi
from
Glendale, CA
Click here to add this to my saved trials
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  12/31/1969
Lakeside Vision Center
mi
from
Irvine, CA
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/31/1969
Lakeside Vision Center
mi
from
Irvine, CA
Click here to add this to my saved trials
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  12/31/1969
Hamilton Glaucoma Center, Shiley Eye Center UCSD
mi
from
La Jolla, CA
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/31/1969
Hamilton Glaucoma Center, Shiley Eye Center UCSD
mi
from
La Jolla, CA
Click here to add this to my saved trials
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  12/31/1969
Atlantis Eye Care
mi
from
Long Beach, CA
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/31/1969
Atlantis Eye Care
mi
from
Long Beach, CA
Click here to add this to my saved trials
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  12/31/1969
Glaucoma Institute of Beverly Hills
mi
from
Los Angeles, CA
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/31/1969
Glaucoma Institute of Beverly Hills
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  12/31/1969
Montebello Medical Eye Center, Inc.
mi
from
Montebello, CA
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/31/1969
Montebello Medical Eye Center, Inc.
mi
from
Montebello, CA
Click here to add this to my saved trials
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  12/31/1969
Stanford University
mi
from
Palo Alto, CA
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/31/1969
Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  12/31/1969
Foothill Eye Institute
mi
from
Pasadena, CA
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/31/1969
Foothill Eye Institute
mi
from
Pasadena, CA
Click here to add this to my saved trials
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  12/31/1969
Martel Eye Medical Group
mi
from
Rancho Cordova, CA
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/31/1969
Martel Eye Medical Group
mi
from
Rancho Cordova, CA
Click here to add this to my saved trials
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  12/31/1969
Grutzmacher, Lewis and Sierra
mi
from
Sacramento, CA
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/31/1969
Grutzmacher, Lewis and Sierra
mi
from
Sacramento, CA
Click here to add this to my saved trials
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  12/31/1969
West Coast Eye Care Associates
mi
from
San Diego, CA
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/31/1969
West Coast Eye Care Associates
mi
from
San Diego, CA
Click here to add this to my saved trials
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  12/31/1969
Pacific Eye Associates
mi
from
San Francisco, CA
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/31/1969
Pacific Eye Associates
mi
from
San Francisco, CA
Click here to add this to my saved trials
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  12/31/1969
Eye Associates of Colorado Springs
mi
from
Colorado Springs, CO
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/31/1969
Eye Associates of Colorado Springs
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  12/31/1969
Palm Beach Eye Center
mi
from
Atlantis, FL
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/31/1969
Palm Beach Eye Center
mi
from
Atlantis, FL
Click here to add this to my saved trials
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  12/31/1969
Nature Coast Clinical Research
mi
from
Crystal River, FL
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/31/1969
Nature Coast Clinical Research
mi
from
Crystal River, FL
Click here to add this to my saved trials
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  12/31/1969
East Florida Eye Institute
mi
from
Stuart, FL
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-angle Glaucoma or Ocular Hypertension
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/31/1969
East Florida Eye Institute
mi
from
Stuart, FL
Click here to add this to my saved trials